Cargando…

Impact of body weight change on clinical outcomes in patients with idiopathic pulmonary fibrosis receiving pirfenidone

There have been limited studies on the association between prognosis and body weight change in patients with idiopathic pulmonary fibrosis (IPF). This single-center retrospective observational study evaluated the impact of weight loss on outcomes in Korean patients with IPF receiving pirfenidone at...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Tae Hun, Shin, Yune-Young, Kim, Hyung-Jun, Song, Myung Jin, Kim, Yeon Wook, Lim, Sung Yoon, Lee, Yeon Joo, Park, Jong Sun, Cho, Young-Jae, Lee, Jae Ho, Lee, Choon-Taek, Kwon, Byoung Soo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576723/ https://www.ncbi.nlm.nih.gov/pubmed/36253395 http://dx.doi.org/10.1038/s41598-022-22449-w

Ejemplares similares

Efficacy of lower dose pirfenidone for idiopathic pulmonary fibrosis in real practice: a retrospective cohort study
por: Hwang, Hyeontaek, et al.
Publicado: (2022)

Correlation of monocyte counts with clinical outcomes in idiopathic nonspecific interstitial pneumonia
por: Kim, Tae Hun, et al.
Publicado: (2023)

Efficacy of Pirfenidone According to Dose in Patients with Idiopathic Pulmonary Fibrosis: A Prospective, Observational, Single-Center Cohort Study
por: Lee, Ho Young, et al.
Publicado: (2023)

Pirfenidone-Induced Lichenoid Drug Eruption in a Patient with Idiopathic Lung Fibrosis
por: Jeong, In Jae, et al.
Publicado: (2019)

Genetic variations in idiopathic pulmonary fibrosis and patient response to pirfenidone
por: Kubbara, Aahd, et al.
Publicado: (2023)

Effectiveness of pirfenidone in idiopathic pulmonary fibrosis according to the autoantibody status: a retrospective cohort study
por: Song, Myung Jin, et al.
Publicado: (2021)

Clinical impact of depression and anxiety in patients with idiopathic pulmonary fibrosis
por: Lee, Ye Jin, et al.
Publicado: (2017)

Usefulness of the BACES score in nontuberculous mycobacterial pulmonary disease for various clinical outcomes
por: Kim, Hyung-Jun, et al.
Publicado: (2023)

Safety and Efficacy of Pirfenidone in Advanced Idiopathic Pulmonary Fibrosis: A Nationwide Post-Marketing Surveillance Study in Korean Patients
por: Chung, Man Pyo, et al.
Publicado: (2020)

Pirfenidone-Induced Photosensitivity in a Patient with Idiopathic Pulmonary Fibrosis
por: Kim, Ho-Jin, et al.
Publicado: (2018)

Real-world experience of adverse reactions-necessitated rifampicin-sparing treatment for drug-susceptible pulmonary tuberculosis
por: Kim, Hyung-Jun, et al.
Publicado: (2023)

Comparative outcomes in patients receiving pirfenidone or nintedanib for idiopathic pulmonary fibrosis
por: Belhassen, Manon, et al.
Publicado: (2021)

Utility and safety of sole electromagnetic navigation bronchoscopy under moderate sedation for lung cancer diagnosis
por: Kim, Yeon Wook, et al.
Publicado: (2022)

Impact of mediastinal lymph node enlargement on the prognosis of idiopathic pulmonary fibrosis
por: Sin, Sooim, et al.
Publicado: (2018)

The significance of elevated tumor markers among patients with interstitial lung diseases
por: Kwon, Byoung Soo, et al.
Publicado: (2022)

Pirfenidone treatment of idiopathic pulmonary fibrosis
por: Gan, Ye, et al.
Publicado: (2011)

Pirfenidone for Idiopathic Pulmonary Fibrosis and Beyond
por: Aimo, Alberto, et al.
Publicado: (2022)

Prognosis of non-small-cell lung cancer in patients with idiopathic pulmonary fibrosis
por: Han, SongYi, et al.
Publicado: (2019)

Efficacy of low dose pirfenidone in idiopathic pulmonary fibrosis: real world experience from a tertiary university hospital
por: Song, Myung Jin, et al.
Publicado: (2020)

Effectiveness of Pharmacist–Physician Collaborative Management for Patients With Idiopathic Pulmonary Fibrosis Receiving Pirfenidone
por: Satsuma, Yukari, et al.
Publicado: (2020)

Evaluation of the synergistic impact of needle and forceps biopsy with electromagnetic navigation bronchoscopy: the CONFIDENT-ENB trial design
por: Kim, Yeon Wook, et al.
Publicado: (2022)

The role of pirfenidone in the treatment of idiopathic pulmonary fibrosis
por: Cottin, Vincent
Publicado: (2013)

Efficacy and safety of pirfenidone for idiopathic pulmonary fibrosis
por: Takeda, Yoshito, et al.
Publicado: (2014)

Effects of comorbid chronic kidney disease on mortality in idiopathic pulmonary fibrosis patients and influence of pirfenidone
por: Jo, Yong Suk, et al.
Publicado: (2023)

Clinical features and long-term prognosis of acute fibrinous and organizing pneumonia histologically confirmed by surgical lung biopsy
por: Kim, Min Chul, et al.
Publicado: (2022)

Differences in detection patterns, characteristics, and outcomes of central and peripheral lung cancers in low-dose computed tomography screening
por: Kim, Yeon Wook, et al.
Publicado: (2021)

A prospective study on the long-term storage of sputum and the recovery of nontuberculous mycobacteria
por: Kwon, Byoung Soo, et al.
Publicado: (2023)

Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosis
por: van Manen, Mirjam J.G., et al.
Publicado: (2017)

Effect of pirfenidone on breathlessness in patients with idiopathic pulmonary fibrosis
por: Glassberg, Marilyn K., et al.
Publicado: (2019)

A Prospective Cohort Study of Bioavailable 25-Hydroxyvitamin D Levels as a Marker of Vitamin D Status in Nontuberculous Mycobacterial Pulmonary Disease
por: Kwon, Byoung-Soo, et al.
Publicado: (2021)

Pirfenidone treatment in idiopathic pulmonary fibrosis: A Saudi experience
por: Alhamad, Esam H.
Publicado: (2015)

Pirfenidone treatment in idiopathic pulmonary fibrosis: nationwide Danish results
por: Salih, Goran Nadir, et al.
Publicado: (2016)

Efficacy and adverse events of pirfenidone in treating idiopathic pulmonary fibrosis
por: Ren, Hui, et al.
Publicado: (2017)

Pirfenidone tablets in idiopathic pulmonary fibrosis: a profile of their use
por: Lyseng-Williamson, Katherine A.
Publicado: (2017)

Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis
por: Flaherty, Kevin R., et al.
Publicado: (2018)

Effect of pirfenidone in patients with more advanced idiopathic pulmonary fibrosis
por: Costabel, Ulrich, et al.
Publicado: (2019)

Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosis
por: Lancaster, Lisa H., et al.
Publicado: (2017)

Prognosis of Small Cell Lung Cancer with Idiopathic Pulmonary Fibrosis: Assessment according to GAP Stage
por: Song, Myung Jin, et al.
Publicado: (2019)

Lung cancer probability and clinical outcomes of baseline and new subsolid nodules detected on low-dose CT screening
por: Kim, Yeon Wook, et al.
Publicado: (2021)

Effects of low-dose pirfenidone on survival and lung function decline in patients with idiopathic pulmonary fibrosis (IPF): Results from a real-world study
por: Lee, Eung Gu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hoc6feimn52u54ccjmib1cr3eo